Miravo Healthcare™ Announces First Quarter 2022 Results
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Jesse Ledger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Press release content from Business Wire. The AP news staff was not involved in its creation.
/PRNewswire/ - August 12, 2021 – Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused...
Miravo Healthcare™ Announces First Quarter 2021 Results News provided by Share this article - - - Miravo to Hold Virtual Annual Meeting May 17th at 9:00 a.m. ET MISSISSAUGA, ON, May 17, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three months ended March 31, 2021. For further details on the results, please refer to Miravo's Management, Discussion...
Location About Miravo Healthcare About Miravo HealthcareMiravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is loca...